TAM
AQST icon

Tyers Asset Management’s Aquestive Therapeutics AQST Stock Holding History

Tyers Asset Management’s Portfolio AQST Stock Details AQST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-2,968
Closed -$13K – 1000
2019
Q2 		$13K Hold
2,968
– – ﹤0.01% 972
2019
Q1 		$20K Buy
+2,968
New +$20.8K ﹤0.01% 954

Other funds holding AQST

BCM
Bratton Capital Management Fort Worth, Texas $40.7M AUM 43.1% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
WS
Wedbush Securities Los Angeles, California $3.88B AUM 32.38% 1-Year Est. Return

Tyers Asset Management's AQST Position: Q3 2019 in Review

Tyers Asset Management sold out of Aquestive Therapeutics (AQST) in Q3 2019, closing a stake of 2,968 shares — an estimated $13K sold.

Tyers Asset Management first reported a position in AQST in Q1 2019 and held it in 2 quarters. The position peaked at $20K in Q1 2019. 35 funds tracked by Wall St. Rank hold AQST as of Q3 2019.

  • Tyers Asset Management reported no remaining Aquestive Therapeutics position as of Q3 2019 after selling out during the quarter.
  • Tyers Asset Management sold 2,968 Aquestive Therapeutics shares in Q3 2019, an estimated $13K.
  • Tyers Asset Management first reported a position in Aquestive Therapeutics in Q1 2019 and held it in 2 quarters.
  • Tyers Asset Management's Aquestive Therapeutics position peaked at $20K in Q1 2019.
  • 35 funds tracked by Wall St. Rank held Aquestive Therapeutics as of Q3 2019.

Based on Tyers Asset Management's 13F filing for Q3 2019, filed 14 Nov 2019.